Anirban Maitra Highlights a Study on Validation of a Computational Histology Artificial Intelligence
Anirban Maitra/LinkedIn

Anirban Maitra Highlights a Study on Validation of a Computational Histology Artificial Intelligence

Anirban Maitra, Director of the Perlmutter Cancer Center, shared a post on X:

“In Journal of Clinical Oncology from Valar Labs

Development and Validation of a Computational Histology Artificial Intelligence–Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer.”

Title: Development and Validation of a Computational Histology Artificial Intelligence–Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer

Authors: Andrew E. Hendifar, Viswesh Krishna, Vrishab Krishna, Haochen Zhang, Asit Tarsode, Vivek Nimgaonkar, Katelyn Smith, Kawther Abdilleh, Snehal Sonawane, Akshay Neema, Ekin Tiu, Brent K. Larson, Vladimir Kazarov, Natalie Moshayedi, Shawn Hutchinson, Daniela Bevacqua, Sudheer Doss, Alejandra Alvarez, Drew Watson, Waleed M. Abuzeid, Barbara T. Grünwald, Marcus Noel, Rashmi Samdani, Dove Keith, Rosalie C. Sears, Davendra Sohal, Christos Fountzilas, Grainne M. O’Kane, Robert C. Grant, Arsen Osipov, Eric A. Collisson, Lesli A. Kiedrowski, Trevor J. Royce, Anirudh R. Joshi, Aatur D. Singhi, Jennifer J. Knox

Read the full article.

Anirban Maitra Highlights a Study on Validation of a Computational Histology Artificial Intelligence

Other articles featuring Anirban Maitra on OncoDaily.